1. Academic Validation
  2. Prothioconazole and prothioconazole-desthio activities against Candida albicans sterol 14-α-demethylase

Prothioconazole and prothioconazole-desthio activities against Candida albicans sterol 14-α-demethylase

  • Appl Environ Microbiol. 2013 Mar;79(5):1639-45. doi: 10.1128/AEM.03246-12.
Josie E Parker 1 Andrew G S Warrilow Hans J Cools Bart A Fraaije John A Lucas Katarina Rigdova William J Griffiths Diane E Kelly Steven L Kelly
Affiliations

Affiliation

  • 1 College of Medicine, Swansea University, Swansea, Wales, UK.
Abstract

Prothioconazole is a new triazolinthione fungicide used in agriculture. We have used Candida albicans CYP51 (CaCYP51) to investigate the in vitro activity of prothioconazole and to consider the use of such compounds in the medical arena. Treatment of C. albicans cells with prothioconazole, prothioconazole-desthio, and voriconazole resulted in CYP51 inhibition, as evidenced by the accumulation of 14α-methylated sterol substrates (lanosterol and eburicol) and the depletion of ergosterol. We then compared the inhibitor binding properties of prothioconazole, prothioconazole-desthio, and voriconazole with CaCYP51. We observed that prothioconazole-desthio and voriconazole bind noncompetitively to CaCYP51 in the expected manner of azole antifungals (with type II inhibitors binding to heme as the sixth ligand), while prothioconazole binds competitively and does not exhibit classic inhibitor binding spectra. Inhibition of CaCYP51 activity in a cell-free assay demonstrated that prothioconazole-desthio is active, whereas prothioconazole does not inhibit CYP51 activity. Extracts from C. albicans grown in the presence of prothioconazole were found to contain prothioconazole-desthio. We conclude that the Antifungal action of prothioconazole can be attributed to prothioconazole-desthio.

Figures
Products